65,437 trials
Healthy
Primary: Overall Peak-to-Peak(PtP) N2/P2-component Amplitude of Laser (Somatosensory/Radiant Heat) Evoked Potentials (LEP) in Ultraviolet B (UVB) -Irradiated Skin — 29.22; 26.08…
Coronary Artery Disease (CAD)
Primary: Number of Participants With a Composite of All-cause Mortality or Non-fatal New Q-wave Myocardial Infarction (MI) — 304; 349 Participants
Kidney Stones
Primary: Stone Clearance Time in mm2/Min — 24.0; 28.9; 32.3 mm^2/min
Multiple Myeloma and Plasma Cell Neoplasm
Primary: Best Response Prior to Tandem Autologous Stem Cell Transplant — 1; 4; 62; 1 Participants
Anesthesia
Primary: Duration of Anesthesia as Measured by Pin Prick Test (PPT) for One Spray CTY-5339-A Compared to One Spray CTY-5339-CB — 17.9; 16.4 minutes — p=0.322
Acute Urinary Tract Infection · Urinary Tract Infection
Primary: The Distribution of Children With Renal Scarring at the Outcome Dimercaptosuccinic Acid (DMSA) Renal Scan — 12; 22; 111; 109 Participants — p=0.16
Parathyroid Disease
Primary: Detection Rate of Parathyroid Adenomas of Anti-3-[18F]FACBC Modality — 80 percentage of adenomas detected
Atrial Fibrillation
Primary: Time to First Atrial Fibrillation (AF) Recurrence or Atrial Flutter Emergence Defined by the Time to First Episode of AF or Atrial Flutter Lasting for at Least 10…
Human Immunodeficiency Virus (HIV) Prophylaxis
Primary: Number of Participants With Specific Graded Adverse Events in Single, Dual, and Triple Antiretroviral (ARV) Intravaginal Rings (IVRs) — 4; 1; 4; 1 participants
Carcinoma of Urinary Tract · Urethral Carcinoma · Carcinoma of Ureter
Primary: Progression-Free Survival (PFS) — 2.8; 5.4; 1.6 months
Arthritis, Psoriatic
Primary: Number of Participants With American College of Rheumatology 20 (ACR20) Response — 47; 45; 21 Participants — p=0.0002
Group B Streptococcal Infections
Primary: Percentage of Participants With Clinical Laboratory Abnormalities at 1-Week After Vaccination as Measured by Food and Drug Administration (FDA) Grade — 0; 6.3; 12.5; 0…
Rheumatoid Arthritis
Primary: Percentage of Participants With a Disease Activity Score 28 (DAS28) Score of <2.6 at Week 52 — 77.1; 61.1 percentage of participants
Presbycusis · Aging · Hearing Loss
Primary: Change in Connected Speech Test (CST) Score — 3.87; -5.84; -9.60 percent-correct words
Major Depressive Disorder
Primary: Changes of Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score — -5.81; -6.97 score on a scale — p=0.53